Future Cardiology

Pharmacogenomics in heart failure: individualizing therapy based on genotype
pp. 129-131(3)
Author: Cavallari, Larisa H

Bulletin Board
pp. 133-135(3)

Sildenafil for pulmonary arterial hypertension
pp. 137-143(7)
Authors: Bartolome, Sonja D; Channick, Richard N

Amlodipine/atorvastatin single pill for the management of hypertensive patients with additional cardiovascular risk factors
pp. 145-159(15)
Author: Blank, Roy

Highlights of late-breaking clinical trials from the 2005 Scientific Sessions of the American Heart Association
pp. 161-164(4)
Authors: Madjid, Mohammad; Ali, Muzammil

High pulse pressure as a marker of preclinical cardiovascular disease
pp. 165-168(4)
Authors: de Simone, Giovanni; Chinali, Marcello

Plasma homocysteine and the genetics of cardiovascular disease
pp. 169-178(10)
Authors: Souto, Juan Carlos; Soria, José Manuel

The effects of apoA-I/C-III/A-IV, apoE and apoB polymorphisms on carotid artery intima–media thickness
pp. 179-186(8)
Authors: Nieminen, Tuomo; Kähönen, Mika; Lehtimäki, Terho

T-cell co-stimulators as anti-inflammatory targets for atherosclerotic disease
pp. 187-195(9)
Author: Wang, Xiaosong

Fluctuations in coagulation activity among patients with atrial fibrillation who are stably anticoagulated
pp. 197-203(7)
Authors: González-Conejero, Rocio; Marín, Francisco; Corral, Javier; Roldán, Vanessa

Optimal antithrombotic treatment in patients with an indication for long-term anticoagulation undergoing coronary artery stenting
pp. 205-213(9)
Authors: Rubboli, Andrea; Di Pasquale, Giuseppe

Clopidogrel resistance: fact and fiction
pp. 215-228(14)
Authors: van Werkum, JW; Heestermans, AACM; Deneer, VHM; Hackeng, CM; ten Berg, JM

Paclitaxel-eluting stents
pp. 229-239(11)
Authors: Cosgrave, John; Corbett, Simon; Babic, Rade; Colombo, Antonio